Zepp Health Gestione
Criteri Gestione verificati 2/4
Zepp Health Il CEO è Wayne Huang, nominato in Jan2013, ha un mandato di 13.33 anni. possiede direttamente 30.09% delle azioni della società, per un valore di $ 40.68M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.9 anni e 5.5 anni.
Informazioni chiave
Wayne Huang
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 13.3yrs |
| Proprietà del CEO | 30.1% |
| Durata media del management | 5.9yrs |
| Durata media del Consiglio di amministrazione | 5.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Zepp Health: A Riskier Bet As Gross Margins Compress (Rating Downgrade)
Summary Zepp Health has shifted from a buy to a neutral rating due to persistent unprofitability and margin concerns. Despite >40% y/y revenue growth in Amazfit, ZEPP faces tough comps and macro headwinds that threaten sustained double-digit expansion. Gross margins remain in the high 30s, ~20 points below Garmin, limiting ZEPP’s scalability and profit potential. With abundant high-quality software bargains available, I see little justification to maintain or add to ZEPP positions. Read the full article on Seeking AlphaInvestors Aren't Entirely Convinced By Zepp Health Corporation's (NYSE:ZEPP) Revenues
With a price-to-sales (or "P/S") ratio of 2x Zepp Health Corporation ( NYSE:ZEPP ) may be sending bullish signals at...Market Participants Recognise Zepp Health Corporation's (NYSE:ZEPP) Revenues Pushing Shares 28% Higher
Despite an already strong run, Zepp Health Corporation ( NYSE:ZEPP ) shares have been powering on, with a gain of 28...Just In: One Analyst Has Become A Lot More Bullish On Zepp Health Corporation's (NYSE:ZEPP) Earnings
Zepp Health Corporation ( NYSE:ZEPP ) shareholders will have a reason to smile today, with the covering analyst making...
GDPR Pressures And AI Health Developments Will Shape Future Markets
Zepp Health's consensus price target has surged, primarily reflecting sharply higher expected revenue growth and a much richer projected valuation multiple, now placing fair value at $60.23. What's in the News Zepp Health issued Q3 2025 revenue guidance of $72–76 million, projecting a 23–35% year-over-year increase from $42.5 million.Zepp Health Corporation (NYSE:ZEPP) Soars 336% But It's A Story Of Risk Vs Reward
Zepp Health Corporation ( NYSE:ZEPP ) shareholders have had their patience rewarded with a 336% share price jump in the...Investors Give Zepp Health Corporation (NYSE:ZEPP) Shares A 29% Hiding
Zepp Health Corporation ( NYSE:ZEPP ) shares have had a horrible month, losing 29% after a relatively good period...
AI-powered T-Rex 3 And Amazfit Releases Will Redefine Future Possibilities
Transition to a high-margin business model and AI-powered product launches likely to enhance profitability and drive significant revenue growth.Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Zepp Health Corporation ( NYSE:ZEPP ) shareholders are no doubt pleased to see that the share price has bounced 26% in...Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Zepp Health fair value estimate is US$0.56 Zepp Health's...Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Zepp Health Corporation ( NYSE:ZEPP ) shares are down a considerable 27% in the...Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
The Zepp Health Corporation ( NYSE:ZEPP ) share price has done very well over the last month, posting an excellent gain...Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Summary Zepp returned to profitability in the third quarter for the first time since 2021, as its margins jumped with the development of its own Amazfit brand. The company’s shares initially rose sharply after the report, but then fell even more, as investors worried about a big drop in sales of its own-brand products. Zepp’s latest valuation metrics look ridiculously low, including a forward P/E ratio of just 3.1 and a P/S ratio of 0.14. Read the full article on Seeking AlphaCan Zepp Health Find Its Way Back Up?
Summary Zepp Health has had the most tumultuous two years. The share price plummeted 88%, and revenue is down by almost 50%. At this point, is ZEPP stock worth investing in? Read the full article on Seeking AlphaZepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Zepp Health press release (NYSE:ZEPP): Q2 Non-GAAP EPADS of -$0.23. Revenue of $165.5M (-39.6% Y/Y). Total units shipped in the second quarter 2022 decreased by 45.2% year-over-year to 6.3M, compared with 11.5M in the second quarter of 2021. For the third quarter of 2022, the management of the company currently expects: Net revenues to be between RMB1.2 billion and RMB1.5 billion, compared with RMB1.61 billion in the third quarter of 2021 vs. estimated growth of 23.50% Y/Y.What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Zepp Health Corporation ( NYSE:ZEPP ), might not be a large cap stock, but it saw a decent share price growth in the...AMMINISTRATORE DELEGATO
Wayne Huang (49 yo)
Mr. Huang Wang, also known as Wayne, is founder and serves as the Chairman of board of Directors and Chief Executive Officer of Zepp Health Corporation (formerly known as Huami Corporation) (the “Company”)...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| COO & Director | 11.3yrs | Nessun dato | 1.05% $ 1.4m | |
| CTO & Director | 4.8yrs | Nessun dato | 2.03% $ 2.7m | |
| Founder | 13.3yrs | Nessun dato | 30.09% $ 40.7m | |
| Chief Financial Officer | 5.6yrs | Nessun dato | 0.69% $ 935.8k | |
| Director of Investor Relations | no data | Nessun dato | Nessun dato | |
| VP of Human Resources | 1.7yrs | Nessun dato | Nessun dato | |
| Chief Industrial Designer | 11.6yrs | Nessun dato | 0.74% $ 1.0m | |
| Chief Technical Advisor of Huami AI Research Institute | 5.9yrs | Nessun dato | Nessun dato |
Gestione esperta: Il team dirigenziale di ZEPP è esperto e expertise (durata media dell'incarico 5.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| COO & Director | 1.7yrs | Nessun dato | 1.05% $ 1.4m | |
| CTO & Director | 1.7yrs | Nessun dato | 2.03% $ 2.7m | |
| Founder | 13.3yrs | Nessun dato | 30.09% $ 40.7m | |
| Independent Director | 5.5yrs | Nessun dato | Nessun dato | |
| Independent Director | 8.3yrs | Nessun dato | Nessun dato | |
| Independent Director | 8.3yrs | Nessun dato | Nessun dato | |
| Director | 1.7yrs | Nessun dato | Nessun dato |
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ZEPP sono considerati esperti (durata media dell'incarico 5.5 anni).
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/20 04:02 |
| Prezzo dell'azione a fine giornata | 2026/05/20 00:00 |
| Utili | 2025/12/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Zepp Health Corporation è coperta da 3 analisti. 1 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Ang-Chi Lin | Citigroup Inc |
| Siddharth Rajeev | Fundamental Research Corp. |
| Jones Ku | Haitong International Research Limited |